Use of individual PK-guided pazopanib dosing: A feasibility study in patients with advanced solid tumors.
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Pazopanib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 09 Nov 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-001567-24).
- 09 Nov 2013 Status changed from planning to recruiting as reported by European Clinical Trials Database.
- 29 Jun 2013 Status changed from not yet recruiting to planning as reported by Netherlands Trial Register.